{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for glutathione root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
NCT02219724: Phase 1 Interventional Completed Neoplasms
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03703102: Phase 2 Interventional Completed Atopic Dermatitis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03703505: Phase 1 Interventional Completed Healthy Volunteers
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01540760: Phase 1 Interventional Completed Healthy Volunteer
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03688178: Phase 2 Interventional Active, not recruiting Glioblastoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03719586: Phase 2/Phase 3 Interventional Completed Ebola Virus
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01222286: Phase 2 Interventional Completed Smoldering Multiple Myeloma
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:porgaviximab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03374943: Phase 1 Interventional Completed Glioblastoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00770354: Phase 2 Interventional Terminated Breast Carcinoma
(2008)
Source URL:
Class:
PROTEIN